Search
Karaya gum
go.drugbank.com/drugs/DB10535ApprovedKaraya gum allergenic extract is used in allergenic testing.
Categories: Drugs for ConstipationNomegestrol
go.drugbank.com/drugs/DB11636ApprovedNomegestrol is an ingredient in the EMA-authorised product Zoely.
Categories: Hormonal Contraceptives for Systemic UseRTP-801i
go.drugbank.com/drugs/DB06048InvestigationalThe proposed primary indication for RTP-801i is the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD or ARMD).
Ezurpimtrostat
go.drugbank.com/drugs/DB16458InvestigationalCategories: Experimental Unapproved Treatments for COVID-19LSALT Peptide
go.drugbank.com/drugs/DB16472InvestigationalCategories: Experimental Unapproved Treatments for COVID-19XC221
go.drugbank.com/drugs/DB16503InvestigationalXC221 was investigated in clinical trials to treat patients with respiratory infections, including influenza, COVID-19, and other acute viral upper respiratory infections.
Categories: Experimental Unapproved Treatments for COVID-19Cariprazine
go.drugbank.com/drugs/DB06016ApprovedInvestigationalCariprazine is an atypical antipsychotic agent and a piperazine derivative that was first developed in Hungary. It works as a partial agonist at central dopamine D2, dopamine D3, and serotonin 5-HT1A receptors and as an antagonist at ser...
Smilagenin
go.drugbank.com/drugs/DB05450InvestigationalP58 therefore provides a totally novel mode of action with potential importance for diseases associated with ageing of the brain. … P58 is one of a family of phytochemicals isolated from traditional treatments for the elderly that have previously been shown to offer significant benefit in the treatment of senile dementia.
Zorubicin
go.drugbank.com/drugs/DB11618ExperimentalZorubicin is a drug of the anthracycline class - a class of medications that have historically demonstrated effective chemotherapy for a variety of cancer types.
Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)
go.drugbank.com/drugs/DB14771InvestigationalPolyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).